Wie hoch ist der Preis für Genetics Generation Advancement Corp. (4160)

Preis für Genetics Generation Advancement Corp. (4160) ist $1.27

Wie hoch ist die Marktkapitalisierung für Genetics Generation Advancement Corp. (4160)

Marktkapitalisierung für Genetics Generation Advancement Corp. (4160) ist $33.91M

Genetics Generation Advancement Corp. (4160) Gewinne

Genetics Generation Advancement Corp. (GGAC), headquartered in Taipei, Taiwan, specializes in providing advanced genetic testing and bioinformatics solutions. The company serves a diverse global clientele across Taiwan, Asia, Europe, and the Americas. GGAC offers a comprehensive array of genetic screenings tailored for various life stages and health needs. These include pre-conception, prenatal, and newborn testing, in addition to adult health management, cancer predisposition, and pharmacogenetic analyses. The company also collaborates with and provides services to institutional partners. Beyond its core genetic services, Genetics Generation Advancement Corp. extends its expertise to encompass life sciences, materials science, sophisticated laboratory informatics, enterprise quality management systems (EQMS), Manufacturing Execution Systems (MES), and efficient electronic data delivery solutions. Originally founded in 2008 as Genesis Genetics Asia Corp., the company officially rebranded and adopted its current name, Genetics Generation Advancement Corp., in February 2016.

Jahr	Gewinn	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Gewinn

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Gewinn	Gewinnunterschied	Land
Thermo Fisher Scientific Inc. TMO.US	$7.61B	-	US
Danaher Corporation DHR.US	$4.76B	-	US
WuXi AppTec Co., Ltd. 603259.SS	-	-	CN
Natera, Inc. NTRA.US	$-252.70M	-	US
IDEXX Laboratories, Inc. IDXX.US	$1.42B	-	US

Unternehmen

Gewinn

Gewinnunterschied

Land